(Adds Capricor response in paragraphs 3 and 6) Nov 20 (Reuters) – The US Food and Drug Administration declined to approve Capricor Therapeutics' experimental cell therapy for a fatal inherited disease
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Niket Nishant Nov 20 (Reuters) - Anthropic's much-hyped arrival on Wall Street fizzled out…
VIDEO SHOWS: ARCHIVE VIDEO OF TOM BRADY, ARCHIVE VIDEO OF CHELSEA HOME STADIUM EXTERIORS SHOWS:…
MEXICO CITY, Nov 20 (Reuters) - Mexican cellphone users reported widespread service outages on Friday…
MEXICO CITY, Nov 20 (Reuters) - Mexican cellphone users reported widespread service outages on Friday…
(Adds comments from local council, context in paragraphs 4-8) By Marco Aquino LIMA, Nov 20…